Anavex Life Sciences Corp (NASDAQ:AVXL)

9.27
Delayed Data
As of 4:02pm ET
 +0.55 / +6.31%
Today’s Change
7.13
Today|||52-Week Range
31.50
-46.54%
Year-to-Date

Today’s Trading

Previous close8.72
Today’s open8.70
Day’s range8.70 - 9.38
Volume44,597
Average volume (3 months)1,101,852
Market cap$661.1M
Data as of 4:02pm ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)-20.26%
Earnings growth (this year)-41.07%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.30

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.04-2.72%
FGENFibroGen Inc+0.15+1.78%
--Oxford BioMedica PLC+0.20+3.48%
NOTVInotiv Inc+0.59+3.31%
Data as of 4:03pm ET, 05/19/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$37.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts